Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease

MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to its experimental gene therapy for a rare, inherited disorder that causes s... ...